1. Home
  2. ANNX vs CCSI Comparison

ANNX vs CCSI Comparison

Compare ANNX & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$3.49

Market Cap

726.1M

Sector

Health Care

ML Signal

N/A

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

N/A

Current Price

$40.93

Market Cap

684.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
CCSI
Founded
2011
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
726.1M
684.3M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
ANNX
CCSI
Price
$3.49
$40.93
Analyst Decision
Buy
Strong Buy
Analyst Count
10
3
Target Price
$17.00
★ $50.00
AVG Volume (30 Days)
★ 3.4M
110.2K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 3.88
Revenue
N/A
★ $349,696,000.00
Revenue This Year
N/A
$3.40
Revenue Next Year
N/A
$4.22
P/E Ratio
★ N/A
$10.45
Revenue Growth
★ N/A
N/A
52 Week Low
$3.36
$20.20
52 Week High
$7.18
$45.68

Technical Indicators

Market Signals
Indicator
ANNX
CCSI
Relative Strength Index (RSI) 36.30 55.90
Support Level N/A $33.37
Resistance Level $4.42 $41.19
Average True Range (ATR) 0.28 2.18
MACD -0.06 0.13
Stochastic Oscillator 10.82 57.20

Price Performance

Historical Comparison
ANNX
CCSI

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

Share on Social Networks: